Warning! GuruFocus detected
1 Severe warning sign
with HLVX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
HilleVax Inc
NAICS : 541714
SIC : 2834
ISIN : US43157M1027
Description
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.58 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -184.7 | |||||
| 3-Year EPS without NRI Growth Rate | -186.7 | |||||
| 3-Year FCF Growth Rate | -213.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 4.84 | |||||
| 9-Day RSI | 12.99 | |||||
| 14-Day RSI | 20.1 | |||||
| 3-1 Month Momentum % | -13.53 | |||||
| 6-1 Month Momentum % | 1.7 | |||||
| 12-1 Month Momentum % | -89.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.25 | |||||
| Quick Ratio | 14.25 | |||||
| Cash Ratio | 13.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -43 | |||||
| Shareholder Yield % | -22.45 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -63.02 | |||||
| ROA % | -49.33 | |||||
| ROIC % | -356.7 | |||||
| 3-Year ROIIC % | -390.1 | |||||
| ROC (Joel Greenblatt) % | -521.56 | |||||
| ROCE % | -52.75 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.37 | |||||
| Price-to-Tangible-Book | 0.37 | |||||
| EV-to-EBIT | 0.52 | |||||
| EV-to-EBITDA | 0.53 | |||||
| EV-to-FCF | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 0.43 | |||||
| Price-to-Net-Cash | 0.45 | |||||
| Earnings Yield (Greenblatt) % | 192.31 | |||||
| FCF Yield % | -179.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HLVX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HilleVax Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 93.24 | ||
| 14-Day RSI | 20.1 | ||
| 14-Day ATR ($) | 0.079586 | ||
| 20-Day SMA ($) | 1.718 | ||
| 12-1 Month Momentum % | -89.24 | ||
| 52-Week Range ($) | 1.37 - 16.66 | ||
| Shares Outstanding (Mil) | 50.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HilleVax Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HilleVax Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
HilleVax Inc Frequently Asked Questions
What is HilleVax Inc(HLVX)'s stock price today?
The current price of HLVX is $1.39. The 52 week high of HLVX is $16.66 and 52 week low is $1.37.
When is next earnings date of HilleVax Inc(HLVX)?
The next earnings date of HilleVax Inc(HLVX) is 2025-04-03 Est..
Does HilleVax Inc(HLVX) pay dividends? If so, how much?
HilleVax Inc(HLVX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers